« Previous
Next »
Journal of Hepatology
Volume 53, Issue 4
, Pages 591-592
, October 2010
Focus
References
- . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655–1669
- . Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. Hepatology. 1994;20:1589–1594
- Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. Am J Physiol Gastrointest Liver Physiol. 2009;296:G147–G156
- Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology. 2009;136:1651–1658
- . Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1695–G1705
- . Pharmacological intervention in renal fibrosis and vascular sclerosis. J Nephrol. 2001;14:332–339
- . Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009;49:306–317
- . The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280–282
- . Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611–1624
- . Placement of transjugular intrahepatic portosystemic shunts in children. Tech Vasc Interv Radiol. 2008;11:235–240
PII: S0168-8278(10)00565-9
doi: 10.1016/j.jhep.2010.06.005
© 2010 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 53, Issue 4
, Pages 591-592
, October 2010
